Novadip Biosciences raised €19M in a Series B round in Nov 2021. The company is based in Ottignies-Louvain-la-Neuve, Belgium. Investors in the round: CR-CP Life Science Fund, Fund plus, Invest BW and 4 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €19M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
